Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Negative-feedback regulation of CD28 costimulation by a novel map-kinase phosphatase, MKP6. That associates physically with the CD28 cytoplasmic tail
    Meeting Abstract

    Marti, F.; Krause, A.; Post, N.; Lyddane, C.; Dupont, B.; Sadelain, M.; King, P. D.
    FASEB Journal (2000)

    Fulltext@MSK | Save
  • Development of targeted ansamycins as novel anti-steroid agents and tyrosine kinase inhibitors in the treatment of breast and prostate cancers
    Meeting Abstract

    Zheng, F. F.; Kuduk, S. D.; Munster, P. N.; Chiosis, G.; Sepp-Lorenzino, L.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Arsenic trioxide (ATO) in relapsed acute promyelocytic leukemia (APL): The combine results and follow-up from the US pilot and multicenter trials
    Meeting Abstract

    Soignet, S. L.; Frankel, S.; Tallman, M.; Douer, D.; Scheinberg, D. A.; Dahlberg, S.; Kantarjian, H.; Stone, R.; Sievers, E.; Kalaycio, M.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Therapeutic levels of hemoglobin produced in bone marrow chimeras expressing lentivirus-encoded human beta-globin
    Meeting Abstract

    Sadelain, M.
    Blood Cells, Molecules, and Diseases (2000)

    Fulltext@MSK | Save
  • Design and synthesis of small molecule inhibitors of the Hsp90 chaperone
    Meeting Abstract

    Chiosis, G.; Timaul, M. N.; Sepp-Lorenzino, L.; Zheng, F. Z. F.; Lucas, B.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Weiss, M. A.; Aliff, T. B.; Tallman, M. S.; Frankel, S. R.; Kalaycio, M. E.; Maslak, P. G.; Scheinberg, D. A.; Roma, T. E.
    Blood (2000)

    Fulltext@MSK | Save
  • Upfront treatment with B43 PAP immunotoxin in newly diagnosed children with higher risk ALL—Childrens Cancer Group 1961
    Meeting Abstract

    Seibel, N. L.; Sather, H.; Steinherz, P. G.; DeLaat, C.; Ettinger, L. J.; Freyer, D.; Hastings, C.; Mattano, L. A.; Mitchell, T. L.; O'Neil, K.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data
    Meeting Abstract

    Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Radford, J. A.; Wahl, R. L.; Rohatiner, A.; Kroll, S.; Stagg, R.; Nadeau, K.; Valente, N.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Combination pentostatin and cyclophosphamide: Complete responses without severe myelosuppression in previously treated patients with CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2000)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save